Bibliometric and visualization analysis in the field of epigenetics and glioma (2009–2024) DOI Creative Commons
Yijun Zeng, Ge Tao, Yong Zeng

и другие.

Frontiers in Oncology, Год журнала: 2024, Номер 14

Опубликована: Окт. 29, 2024

Glioma represents the most prevalent primary malignant tumor in central nervous system, a deeper understanding of underlying molecular mechanisms driving glioma is imperative for guiding future treatment strategies. Emerging evidence has implicated close relationship between development and epigenetic regulation. However, there remains significant lack comprehensive summaries this domain. This study aims to analyze publications pertaining gliomas from 2009 2024 using bibliometric methods, consolidate extant research, delineate prospects investigation critical area.

Язык: Английский

Navigating the Brain: Harnessing Endogenous Cellular Hitchhiking for Targeting Neoplastic and Neuroinflammatory Diseases DOI Creative Commons

Suraj Wagh,

Paras Famta,

Saurabh Shah

и другие.

Asian Journal of Pharmaceutical Sciences, Год журнала: 2025, Номер 20(2), С. 101040 - 101040

Опубликована: Фев. 27, 2025

Cellular hitchhiking is an emerging therapeutic strategy that uses endogenous cell migration mechanism to deliver therapeutics specific sites in the body. Owing low permeability and presence of blood-brain barrier (BBB), targeted delivery limited, leading inadequate localization brain. NCs fail extravasate significantly into tumor microenvironment (TME), demonstrating poor accumulation penetration. The novel cellular concept has been utilized promote systemic half-life targeting. Neoplastic neuroinflammatory diseases brain, including glioblastoma neuroinflammation, face critical hurdles for efficiently delivering entities owing BBB. can surmount these by utilizing various populations, such as stem cells, monocytes/macrophages, neutrophils, platelets, potential functional carriers cargo through These carrier cells have innate capability traverse BBB, transit brain parenchyma, specifically reach disease inflammatory neoplastic lesions chemotactic navigation, i.e., movement attributed chemical stimuli. Chemotherapeutic drugs delivered achieve tumor-specific targeting discussed. This article explores types TME with in-depth mechanisms characterization techniques decipher backpack dissociation dynamics (nanoparticle payload detachment characteristics from hitchhiked cells) challenges toward prospective clinical translation.

Язык: Английский

Процитировано

4

Self‐Sustained Biophotocatalytic Nano‐Organelle Reactors with Programmable DNA Switches for Combating Tumor Metastasis DOI Creative Commons

Wenshuai Han,

Jiang‐Qiao Ding,

Bo Qiao

и другие.

Advanced Materials, Год журнала: 2025, Номер unknown

Опубликована: Янв. 10, 2025

Abstract Metastasis, the leading cause of mortality in cancer patients, presents challenges for conventional photodynamic therapy (PDT) due to its reliance on localized light and oxygen application tumors. To overcome these limitations, a self‐sustained organelle‐mimicking nanoreactor is developed here with programmable DNA switches that enables bio‐chem‐photocatalytic cascade‐driven starvation‐photodynamic synergistic against tumor metastasis. Emulating compartmentalization positional assembly strategies found living cells, this nano‐organelle reactor allows quantitative co‐compartmentalization multiple functional modules designed self‐illuminating chemiexcited PDT system. Within space‐confined nanoreactor, biofuel glucose converted hydrogen peroxide (H 2 O ) which enhances luminol‐based chemiluminescence (CL), consequently driving generation photochemical singlet ( 1 via resonance energy transfer. Meanwhile, hemoglobin functions as synchronized supplier both oxidation PDT, while also exhibiting peroxidase‐like activity produce hydroxyl radicals (·OH). Crucially, keeps switching off normal tissues, on‐demand activation tumors through toehold‐mediated strand displacement. These findings demonstrate self‐sufficient precise striking tumors, promising paradigm managing highly metastatic cancers.

Язык: Английский

Процитировано

2

Application of Surface-Enhanced Raman Spectroscopy in Head and Neck Cancer Diagnosis DOI
Bowen Yang,

Xiaobo Dai,

Shuai Chen

и другие.

Analytical Chemistry, Год журнала: 2025, Номер unknown

Опубликована: Фев. 14, 2025

Surface-enhanced Raman spectroscopy (SERS) has emerged as a crucial analytical tool in the field of oncology, particularly presenting significant challenges for diagnosis and treatment head neck cancer. This Review provides an overview current status prospects SERS applications, highlighting their profound impact on molecular biology-level diagnosis, tissue-level identification, HNC therapeutic monitoring, integration with emerging technologies. The application single-molecule assays such epidermal growth factor receptors PD-1/PD-L1, gene expression analysis, tumor microenvironment characterization is also explored. showcases innovative applications liquid biopsies high-throughput lateral flow analysis ctDNA quantification salivary diagnostics, which can offer rapid highly sensitive suitable immediate detection. At tissue level, enables cancer cell visualization intraoperative margin enhancing surgical precision decision-making. role radiotherapy, chemotherapy, targeted therapy examined along its use real-time pharmacokinetic studies to monitor response. Furthermore, this delves into synergistic relationship between artificial intelligence, encompassing machine learning deep algorithms, marking dawn new era oncology. genomics, metabolomics, transcriptomics, proteomics, single-cell omics at multiomics level will revolutionize our comprehension management HNC. offers transformative impacts examines future directions well dynamic research field.

Язык: Английский

Процитировано

2

Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention DOI Creative Commons

Lin Tang,

Peng Shen, Xiaoying Zhuang

и другие.

MedComm – Oncology, Год журнала: 2025, Номер 4(1)

Опубликована: Фев. 17, 2025

ABSTRACT Metastasis remains a leading cause of cancer‐related deaths, defined by complex, multi‐step process in which tumor cells spread and form secondary growths distant tissues. Despite substantial progress understanding metastasis, the molecular mechanisms driving this development effective therapies remain incompletely understood. Elucidating pathways governing metastasis is essential for discovery innovative therapeutic targets. The rapid advancements sequencing technologies expansion biological databases have significantly deepened our drivers associated drug resistance. This review focuses on particularly roles genetic mutations, epigenetic changes, post‐translational modifications progression. We also examine how microenvironment influences metastatic behavior explore emerging strategies, including targeted immunotherapies. Finally, we discuss future research directions, stressing importance novel treatment approaches personalized strategies to overcome improve patient outcomes. By integrating contemporary insights into basis innovation, provides comprehensive framework guide clinical cancer.

Язык: Английский

Процитировано

1

Nanomaterials in gastric cancer: pioneering precision medicine for diagnosis, therapy, and prevention DOI

Tiantian Liu,

Ying-Qiu Gu, Zaili Yang

и другие.

Medical Oncology, Год журнала: 2025, Номер 42(4)

Опубликована: Март 6, 2025

Язык: Английский

Процитировано

1

Quantitative immunoassay of prostate-specific antigen dependent on SERS substrate of polymer-silver nanocubes modified with 4-mercaptobenzoic acid: the crucial effect of thiol molecule as internal standard DOI

Wenting Lan,

Changgan Lai,

Yasheng Dai

и другие.

Talanta, Год журнала: 2025, Номер 294, С. 128252 - 128252

Опубликована: Май 1, 2025

Язык: Английский

Процитировано

1

Peptide-functionalized gold nanostars-assisted single-cell Raman spectra for molecular analysis of tumor metastasis based on cancer stem cells DOI

Zhiyi Peng,

Han Yao, Junqi Li

и другие.

Talanta, Год журнала: 2025, Номер 286, С. 127525 - 127525

Опубликована: Янв. 7, 2025

Язык: Английский

Процитировано

1

Aggregation induced emission luminogen bacteria hybrid bionic robot for multimodal phototheranostics and immunotherapy DOI Creative Commons
Liwei Zhu,

Guangjie Song,

Wentian Zhang

и другие.

Nature Communications, Год журнала: 2025, Номер 16(1)

Опубликована: Март 15, 2025

Multimodal phototheranostics utilizing single molecules offer a "one-and-done" approach, presenting convenient and effective strategy for cancer therapy. However, therapies based on conventional photosensitizers often suffer from limitations such as photosensitizing mechanism, restricted tumor penetration retention, the requirement multiple irradiations, which significantly constrain their application. In this report, we present an aggregation-induced emission luminogen (AIEgen) bacteria hybrid bionic robot to address above issues. This is composed of multifunctional AIEgen (INX-2) Escherichia coli Nissle 1917 (EcN), i.e., EcN@INX-2. The EcN@INX-2 exhibits near-infrared II (NIR-II) fluorescence demonstrates efficient photodynamic photothermal effects, well tumor-targeting capabilities. These features are facilitated by complementary roles INX-2 EcN. successfully enables in vivo multimodal imaging therapy colon models female mice through various mechanisms, including activation anti-tumor immunity, Our study paves avenue designing diagnostic agents targeted image-guided combinational immunotherapy. utility hindered need limited retention. Here, authors these issues developing that activates immunity.

Язык: Английский

Процитировано

1

Rationally designed NIR-II excitable and endoplasmic reticulum-targeted molecular phototheranostics for imaging-guided enhanced photoimmunotherapy of triple-negative breast cancer DOI Creative Commons
Fen Liu, Qiang Kang, Hao Xiao

и другие.

Journal of Nanobiotechnology, Год журнала: 2025, Номер 23(1)

Опубликована: Март 22, 2025

Triple-negative breast cancer (TNBC) is a highly aggressive subtype of characterized by an extremely poor prognosis. Photoimmunotherapy has emerged as promising strategy for the treatment TNBC. This approach works selectively destroying tumor cells, releasing tumor-associated antigens, activating immune system, and effectively inhibiting proliferation metastasis. However, majority current phototheranostic approaches are hindered limited tissue penetration in first near-infrared (NIR-I) ultraviolet–visible (UV–Vis) regions. Additionally, due to lack specific subcellular targets, it may be difficult treat deep-seated lesions with ambiguous extensive boundaries caused TNBC metastases. Consequently, development effective, deep-penetrating, organelle-targeted phototheranostics essential enhancing outcomes work proposes novel molecular design NIR-II realize planar rigid conjugation alkyl chain functionalization. The di-hexaalkyl chains vertical configuration on donor (4H-cyclopenta[2,1-b:3,4-b'] dithiophene) shielding units (fluorene) introduced construct S-D-A-D-S type (IR-FCD). structure IR-FCD exhibits robust intramolecular charge transfer capability, lower band gap, enhanced photon absorption properties, significant steric hindrance from vertically arranged minimize non-radiative energy loss. By incorporating N-(but-3-yn-1-yl)-4-methylbenzenesulfonamide at terminus elongated chain, followed self-assembly into DSPE-S-S-PEG2000, excitable (IR-FCD-Ts NPs) endoplasmic reticulum (ER) targeting capability were successfully synthesized imaging-guided photoimmunotherapy IR-FCD-Ts NPs demonstrate exceptional optical characteristics, maximum 1068 nm (extending 1300 nm) emission 1273 1700 nm), along high molar coefficient 2.76*104 L/mol·c 1064 aqueous solution. Under exposure laser irradiation, exhibit superior photothermal properties have potential photodynamic therapy. ER, thereby inducing ER stress significantly immunogenic cell death (ICD) triggers strong antitumor response inhibits metastasis

Язык: Английский

Процитировано

1

Caveolin-1: an ambiguous entity in breast cancer DOI Creative Commons

Naveen Chintalaramulu,

Dhirendra P. Singh,

Biplov Sapkota

и другие.

Molecular Cancer, Год журнала: 2025, Номер 24(1)

Опубликована: Апрель 7, 2025

Breast cancer (BC) is the most frequently diagnosed in women and second leading cause of death from among women. Metastasis major BC-associated mortality. Accumulating evidence implicates Caveolin-1 (Cav-1), a structural protein plasma membrane caveolae, BC metastasis. Cav-1 exhibits dual role, as both tumor suppressor promoter depending on cellular context subtype. This review highlights role modulating glycolytic metabolism, tumor-stromal interactions, apoptosis, senescence. Additionally, stromal Cav-1's expression identified potential prognostic marker, offering insights into its contrasting roles suppression progression. Furthermore, context-dependent effects are explored subtypes including hormone receptor-positive, HER2-positive, triple-negative (TNBC). The further delves regulating metastatic cascade extracellular matrix cell migration invasion, premetastatic niche formation. later sections discuss therapeutic targeting by metabolic inhibitors such betulinic acid compounds. While may be biomarker target, heterogeneous context-specific activity necessitates research to develop precise interventions. Future studies investigating mechanistic metastasis pave way for effective treatment BC.

Язык: Английский

Процитировано

1